Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,348.00 GBX | -4.60% |
|
-4.30% | +0.11% |
07-18 | US FDA advisers recommend against Otsuka's PTSD combination treatment | RE |
07-18 | Health Care Declines as Traders Hedge on Growth Views - Health Care Roundup | DJ |
Chart calendar GSK plc
c40b73c9d5211c34eb2410815.-KLvDwWClAzpSZkGyPiW0DTDjGZRMv4ugooJJuGGKBM.rfGmTGfg7UmFE8Nin7DkpEKJ_0sdCpNhw9A_HtnAUFKUlp5lcsT_a50s1A~dcebbe62660f5d8ef5000a74a248f89e
Upcoming events on GSK plc
Past events on GSK plc
Past dividends on GSK plc
2025-05-14 | Interim Payment 0.16 GBP |
2025-02-19 | Final Payment 0.16 GBP |
2024-11-13 | Interim Payment 0.15 GBP |
2024-08-14 | Interim Payment 0.15 GBP |
2024-05-15 | Interim Payment 0.15 GBP |
2024-02-21 | Final Payment 0.16 GBP |
2023-11-15 | Interim Payment 0.14 GBP |
2023-08-16 | Interim Payment 0.14 GBP |
2023-05-17 | Interim Payment 0.14 GBP |
2023-02-22 | Final Payment 0.1375 GBP |
2022-11-16 | Interim Payment 0.1375 GBP |
2022-08-17 | Interim Payment 0.1625 GBP |
2022-05-18 | Interim Payment 0.14 GBP |
2022-02-23 | Final Payment 0.23 GBP |
2021-11-17 | Interim Payment 0.19 GBP |
2021-08-18 | Interim Payment 0.19 GBP |
2021-05-19 | Interim Payment 0.19 GBP |
2021-02-17 | Final Payment 0.23 GBP |
2020-11-11 | Interim Payment 0.19 GBP |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 29 324 29 105 0.75% | 30 328 29 850 1.6% | 31 376 31 163 0.68% | 31 946 | 33 594 | 35 159 |
EBITDA Million GBP | Released Forecast Spread | 10 449 9 257 12.88% | 11 635 10 203 14.04% | 10 693 10 130 5.56% | 10 751 | 11 680 | 12 399 |
EBIT Million GBP | Released Forecast Spread | 8 151 7 952 2.5% | 8 786 8 780 0.07% | 9 148 9 011 1.52% | 9 500 | 10 317 | 11 028 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 5 628 5 548 1.45% | 6 064 7 498 -19.12% | 3 477 4 752 -26.83% | 7 068 | 8 322 | 9 327 |
Net income Million GBP | Released Forecast Spread | 14 956 6 238 139.74% | 4 928 5 481 -10.09% | 2 575 3 509 -26.63% | 5 656 | 6 343 | 6 755 |
EPS GBP | Released Forecast Spread | 3,66 1,66 120.52% | 1,22 1,38 -11.61% | 0,63 0,85 -25.46% | 1,41 | 1,58 | 1,69 |
Announcement Date | 01/02/23 | 31/01/24 | 05/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 8 147 7 727 5.43% | 8 052 7 621 5.65% | 7 363 7 049 4.45% | 7 884 7 493 5.21% | 8 012 8 007 0.06% | 8 117 7 751 4.73% | 7 516 7 455 0.82% | 7 821 | 8 165 | 8 333 | 7 615 | 8 275 | 8 660 | 8 835 |
EBITDA Million GBP | Released Forecast Spread | 3 351 3 072 9.09% | 2 930 2 094 39.93% | 2 992 2 406 24.36% | 3 152 2 502 25.98% | 3 712 2 788 33.12% | 837 1 650 -49.29% | 3 356 2 603 28.94% | 2 700 | 2 993 | 1 922 | ||||
EBIT Million GBP | Released Forecast Spread | 2 772 2 570 7.88% | 1 752 1 836 -4.58% | 2 443 2 099 16.38% | 2 513 2 205 13.97% | 2 761 2 463 12.1% | 1 431 1 330 7.6% | 2 533 2 302 10.03% | 2 464 | 2 762 | 1 640 | 2 524 | 2 720 | 3 150 | 1 805 |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 1 791 2 225 -19.51% | 379 1 361 -72.15% | 1 355 1 696 -20.11% | 1 495 1 818 -17.77% | 64,0 2 023 -96.84% | 563 919 -38.74% | 2 108 | |||||||
Net income Million GBP | Released Forecast Spread | 1 464 1 739 -15.79% | 350 834 -58.04% | 1 046 1 297 -19.32% | 1 173 1 386 -15.4% | -58,0 623 -109.31% | 414 750 -44.82% | 1 624 1 349 20.39% | 1 396 | 1 638 | 882 | ||||
EPS GBP | Released Forecast Spread | 0,36 0,43 -15.26% | 0,09 0,20 -58.02% | 0,25 0,31 -19.17% | 0,29 0,34 -15.05% | -0,01 0,15 -109.28% | 0,10 0,18 -44.32% | 0,39 0,32 20.94% | 0,34 | 0,40 | 0,22 | ||||
Announcement Date | 01/11/23 | 31/01/24 | 01/05/24 | 31/07/24 | 30/10/24 | 05/02/25 | 30/04/25 | - | - | - | - | - | - | - |
More events
Past sector events for GSK plc
2025-07-18 07:10 | AARTI DRUGS LIMITED: Q1 2026 Earnings Release |
2025-07-18 05:00 | ORION OYJ: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-17 01:00 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-17 01:00 | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-16 06:45 | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-10 04:22 | LOTUS PHARMACEUTICAL CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 19:51 | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GSK Stock
- Calendar GSK plc
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition